HTS 2918 · Canada · duty record
Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides and peroxyacids; their halogenated, sulfonated, nitrated or nitrosated derivatives
Product description (continued): Goods in HTS heading 2918 from Canada pay the general duty in the tariff schedule plus Section 301 10%. Across the 62 lines below the percentage total runs from 0% to 16.5%. Section 232 is added to the totals only where a plain percentage applies to the line and the country (conditional and country-deal rates are listed, not added), we found no IEEPA duty in force, and antidumping duties are not checked here.
Selected line / duty components
General schedule rate: 5.1%
Lactic acid, its salts and esters › Lactic acid
Click any code in the table below to show that line here.
Duty by line
62 tariff lines · CanadaPick your own 10-digit code from your classification or broker: the rate that applies to you is the one on your line. The last column is the percentage part only, on $10,000 of customs value.
62 lines shown
| Code | Product | General rate | Added duties | Total percentage | On $10,000 |
|---|---|---|---|---|---|
| Lactic acid, its salts and esters › Lactic acid | 5.1% | 10% Section 301 · adds | 15.1% | $1,510.00 | |
| Lactic acid, its salts and esters › Other | 3.4% | none in our table | 3.4% | $340.00 | |
| Carboxylic acids with alcohol function but without other oxygen function, their anhydrides, halides, peroxides, peroxyacids and their derivatives › Tartaric acid | Free | none in our table | 0% | $0.00 | |
| Salts and esters of tartaric acid › Potassium antimony tartrate (Tartar emetic) | Free | 10% Section 301 · adds | 10% | $1,000.00 | |
| Salts and esters of tartaric acid › Potassium bitartrate (Cream of tartar) | Free | 10% Section 301 · adds | 10% | $1,000.00 | |
| Salts and esters of tartaric acid › Potassium sodium tartrate (Rochelle salts) | Free | 10% Section 301 · adds | 10% | $1,000.00 | |
| Salts and esters of tartaric acid › Other | 4.4% | none in our table | 4.4% | $440.00 | |
| Carboxylic acids with alcohol function but without other oxygen function, their anhydrides, halides, peroxides, peroxyacids and their derivatives › Citric acid | 6% | none in our table | 6% | $600.00 | |
| Salts and esters of citric acid › Sodium citrate | 6.5% | 10% Section 301 · adds | 16.5% | $1,650.00 | |
| Salts and esters of citric acid › Other | 3.7% | 10% Section 301 · adds | 13.7% | $1,370.00 | |
| Gluconic acid, its salts and esters › Gluconic acid | 6% | 10% Section 301 · adds | 16% | $1,600.00 | |
| Other › Sodium gluconate | 3.7% | none in our table | 3.7% | $370.00 | |
| Other › Calcium gluconate | 3.7% | none in our table | 3.7% | $370.00 | |
| Other › Other | 3.7% | none in our table | 3.7% | $370.00 | |
| Carboxylic acids with alcohol function but without other oxygen function, their anhydrides, halides, peroxides, peroxyacids and their derivatives › 2,2-Diphenyl-2-hydroxyacetic acid (benzilic acid) | 5.8% | 10% Section 301 · adds | 15.8% | $1,580.00 | |
| Carboxylic acids with alcohol function but without other oxygen function, their anhydrides, halides, peroxides, peroxyacids and their derivatives › Chlorobenzilate (ISO) | 6.5% | none in our table | 6.5% | $650.00 | |
| Aromatic › Benzilic acid, methyl ester | 5.8% | 10% Section 301 · adds | 15.8% | $1,580.00 | |
| Other › Mandelic acid | Free | 10% Section 301 · adds | 10% | $1,000.00 | |
| Other › Other | 6.5% | none in our table | 6.5% | $650.00 | |
| Other › Products described in additional U.S. note 3 to section VI | 6.5% | none in our table | 6.5% | $650.00 | |
| Other › Other | 6.5% | none in our table | 6.5% | $650.00 | |
| Other › Malic acid | 4% | none in our table | 4% | $400.00 | |
| Other › Other | 4% | none in our table | 4% | $400.00 | |
| Salicylic acid and its salts › Suitable for medicinal use | 6.5% | none in our table | 6.5% | $650.00 | |
| Salicylic acid and its salts › Other | 6.5% | 10% Section 301 · adds | 16.5% | $1,650.00 | |
| O-Acetylsalicylic acid, its salts and esters › O-Acetylsalicylic acid (Aspirin) | 6.5% | none in our table | 6.5% | $650.00 | |
| O-Acetylsalicylic acid, its salts and esters › Salts and esters of O-acetylsalicylic acid | 6.5% | none in our table | 6.5% | $650.00 | |
| Other esters of salicylic acid and their salts › Salol (Phenyl salicylate) suitable for medicinal use | 6.5% | none in our table | 6.5% | $650.00 | |
| Other esters of salicylic acid and their salts › Odoriferous or flavoring compounds | 6.5% | 10% Section 301 · adds | 16.5% | $1,650.00 | |
| Other esters of salicylic acid and their salts › Products described in additional U.S. note 3 to section VI | 6.5% | none in our table | 6.5% | $650.00 | |
| Other esters of salicylic acid and their salts › Other | 6.5% | none in our table | 6.5% | $650.00 | |
| Other › 2,3-Cresotic acid; 2-Hydroxybenzoic acid, calcium salt; 1-Hydroxy-2-naphthoic acid; 2-Hydroxy-1-naphthoic acid; 1-Hydroxy-2-naphthoic acid, phenyl ester;α-Resorcylic acid;γ-Resorcylic acid; and 5-Sulfosalicylic acid | 5.8% | 10% Section 301 · adds | 15.8% | $1,580.00 | |
| Other › 1,6-Hexanediol bis(3,5-dibutyl-4-hydroxyphenyl)propionate) | 5.8% | 10% Section 301 · adds | 15.8% | $1,580.00 | |
| Other › m-Hydroxybenzoic acid | Free | 10% Section 301 · adds | 10% | $1,000.00 | |
| Other › Gentisic acid; and Hydroxycinnamic acid and its salts | 6.5% | none in our table | 6.5% | $650.00 | |
| Other › p-Hydroxybenzoic acid | 6.5% | none in our table | 6.5% | $650.00 | |
| Other › 3-Hydroxy-2-naphthoic acid | 6.5% | 10% Section 301 · adds | 16.5% | $1,650.00 | |
| Other › Gallic acid | 1% | 10% Section 301 · adds | 11% | $1,100.00 | |
| Other › 4,4-Bis(4-hydroxyphenyl) pentanoic acid; and 3,5,6-Trichlorosalicylic acid | Free | 10% Section 301 · adds | 10% | $1,000.00 | |
| Other › Products described in additional U.S. note 3 to section VI | 6.5% | none in our table | 6.5% | $650.00 | |
| Other › Other | 6.5% | none in our table | 6.5% | $650.00 | |
| Aromatic › 1-Formylphenylacetic acid, methyl ester | 5.8% | none in our table | 5.8% | $580.00 | |
| Aromatic › 2-Chloro-4,5-difluoro-ß-oxobenzenepropanoic acid, ethyl ester; and Ethyl 2-keto-4-phenylbutanoate | Free | none in our table | 0% | $0.00 | |
| Products described in additional U.S. note 3 to section VI › Methyl 3-oxo-2-phenylbutanoate (methyl alpha-phenylacetoacetate, MAPA) | 6.5% | none in our table | 6.5% | $650.00 | |
| Products described in additional U.S. note 3 to section VI › Other | 6.5% | none in our table | 6.5% | $650.00 | |
| Carboxylic acids with aldehyde or ketone function but without other oxygen function, their anhydrides, halides, peroxides, peroxyacids and their derivatives › Other | 6.5% | none in our table | 6.5% | $650.00 | |
| Other › Dimethyl acetyl succinate; Oxalacetic acid diethyl ester, sodium salt; 4,4,4-Trifluoro-3-oxobutanoic acid, ethyl ester; and 4,4,4-Trifluoro-3-oxobutanoic acid, methyl ester | Free | none in our table | 0% | $0.00 | |
| Other › Other | 3.7% | none in our table | 3.7% | $370.00 | |
| Other › 2,4,5-T (ISO) (2,4,5-trichlorophenoxyacetic acid), its salts and esters | 6.5% | 10% Section 301 · adds | 16.5% | $1,650.00 | |
| Aromatic › p-Anisic acid; Clofibrate; and 3-Phenoxybenzoic acid | 5.8% | none in our table | 5.8% | $580.00 | |
| Aromatic › 1-Hydroxy-6-octadecyloxy-2-naphthalene- carboxylic acid; and 1-Hydroxy-6-docosyloxy-2-naphthalene- carboxylic acid | Free | 10% Section 301 · adds | 10% | $1,000.00 | |
| Aromatic › 2-(4-Chloro-2-methylphenoxy)propionic acid and its salts | Free | 10% Section 301 · adds | 10% | $1,000.00 | |
| Other › 4-(4-Chloro-2-methylphenoxy) butyric acid;p-Chlorophenoxyacetic acid; and 2-(2,4-Dichlorophenoxy) propionic acid | 6.5% | 10% Section 301 · adds | 16.5% | $1,650.00 | |
| Other › 2,4-Dichlorophenoxyacetic acid, its salts and esters | 6.5% | 10% Section 301 · adds | 16.5% | $1,650.00 | |
| Other › 2-Methyl-4-chlorophenoxyacetic acid | 6.5% | 10% Section 301 · adds | 16.5% | $1,650.00 | |
| Other › Other | 6.5% | 10% Section 301 · adds | 16.5% | $1,650.00 | |
| Other › Drugs | 6.5% | none in our table | 6.5% | $650.00 | |
| Other › Odoriferous or flavoring compounds | 6.5% | 10% Section 301 · adds | 16.5% | $1,650.00 | |
| Products described in additional U.S. note 3 to section VI › 2-Methyl-3-phenyloxirane-2-carboxylic acid (P-2-P methyl glycidic acid), its salts and esters | 6.5% | none in our table | 6.5% | $650.00 | |
| Products described in additional U.S. note 3 to section VI › Other | 6.5% | none in our table | 6.5% | $650.00 | |
| Other › Other | 6.5% | none in our table | 6.5% | $650.00 | |
| Other › Other | 4% | none in our table | 4% | $400.00 |
What is and is not counted
Rules applied to Canada
- 10% Section 301 since 2026-07-24 — source (9903.05.20-9903.05.84 (headings by country))
2026 Section 301 action (91 FR 47318, U.S. note 52): 10% on top of the general rate, from 24 July 2026, for the countries named in headings 9903.05.22, 9903.05.26, 9903.05.28, 9903.05.29, 9903.05.35, 9903.05.37, 9903.05.40, 9903.05.42, 9903.05.44, 9903.05.45, 9903.05.50, 9903.05.54, 9903.05.55, 9903.05.62, 9903.05.72, 9903.05.78, 9903.05.81. Not charged on goods the note exempts (agricultural list, civil aircraft, pharmaceuticals, and every product on a Section 232 list); other exemptions (Canada and Mexico goods that enter free under USMCA, CAFTA-DR textiles, country-specific lists) are not modelled.
Section 232: what the proclamations say about chapter 29
These are summaries of the official proclamations. Where the tariff schedule notes give a plain percentage for your line and country, it is already in the duty above (see the layer list). Rates that depend on a fact only you know (the share of metal by weight, U.S.-made metal, a country deal, a USMCA claim) are listed but not added. Check your own line against the official list or ask your broker.
Pharmaceuticals and pharmaceutical ingredients in force
- Proclamation 11020 (2026-04-09). USITC HTS 2026HTSRev23, U.S. note 40 and headings 9903.04.60 to 9903.04.70. Patented pharmaceutical articles: total rate 100% (heading 9903.04.60); 15% total for products of Japan, the EU, South Korea, Switzerland and Liechtenstein (9903.04.62); the United Kingdom +0% (9903.04.63); +20% for companies with an approved onshoring plan (9903.04.64). Generic products, orphan drugs, nuclear medicines, plasma therapies, fertility treatments, cell and gene therapies, clinical-trial products and several other groups pay nothing extra (9903.04.61, .65 to .70).
- Product list (added 2026-11-21): 149 code prefixes parsed from note 40(c) (chapters 29 and 30). Whether the duty applies depends on patent status and the importer, which the product code cannot show, so every row is listed and none is added to totals. The pack holds neither chapter 29 nor chapter 30, so no tariff line of the site resolves to these rows yet.
Read from the proclamation on 2026-11-21. Sources: Proclamation 11020 (Federal Register document 2026-06956)
Pending and recent notices for this heading
None of the notices we track names heading 2918 and Canada together. Many notices name only a program or a chapter, so also read all pending notices.